Home/Medicines/Ciprofloxacin (Ophthalmic)
All medicines

Ciprofloxacin (Ophthalmic)

Prescription
Fluoroquinolone antibiotic (ophthalmic)
Last reviewed 19 Apr 2026 · PetCare.AI Editorial Team
Species
Dog, Cat
Brands
3 available
Formulations
2

Mechanism of action

Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication; broad-spectrum activity against ocular pathogens

At a glance

Class
Fluoroquinolone antibiotic (ophthalmic)
Schedule
Prescription
Storage
Store below 25°C, protect from light

Dosing

🐕

Dog

Bacterial conjunctivitis / Corneal ulcer (superficial, non-melting)
Dose
0 mg/kg
Route
Ophthalmic
Frequency
QID (q4–6h); hourly for first 24–48h in severe ulcers
Max dose
0 mg
Duration: 7–14 days; continue 48h past resolution
🐈

Cat

Bacterial conjunctivitis / Secondary bacterial infection
Dose
0 mg/kg
Route
Ophthalmic
Frequency
QID
Max dose
0 mg
Duration: 7–14 days

Formulations

🧴

Ophthalmic solution — 1

Strength
0.3%
Available in India
🧪

Ophthalmic ointment — 1

Strength
0.3%
Available in India

Storage

Store below 25°C, protect from light

Safety

Use with caution

  • Fluoroquinolone hypersensitivity
  • Fungal or viral keratitis
    Antibiotic may delay diagnosis

Adverse effects

Common
Transient ocular stinging
White corneal precipitate (crystalline deposits)
Serious
Corneal toxicity (rare with prolonged use)

Monitoring parameters

Clinical responseFluorescein stainingCorneal health

Interactions

No documented interactions.

Brands

International

Ciloxan
Alcon

India

Ciplox Eye
Cipla
Zoxan-D
FDC Limited

FAQs

Frequently asked questions

What is Ciprofloxacin (Ophthalmic)?
Ciprofloxacin (Ophthalmic) is a fluoroquinolone antibiotic (ophthalmic) used in pets. Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication; broad-spectrum activity against ocular pathogens
What is Ciprofloxacin (Ophthalmic) used for in pets?
Ciprofloxacin (Ophthalmic) is used in veterinary medicine for: Bacterial conjunctivitis / Corneal ulcer (superficial, non-melting); Bacterial conjunctivitis / Secondary bacterial infection.
What is the Ciprofloxacin (Ophthalmic) dose for dogs?
For dogs, Ciprofloxacin (Ophthalmic) is typically dosed as follows — Bacterial conjunctivitis / Corneal ulcer (superficial, non-melting): 0 mg/kg Ophthalmic QID (q4–6h); hourly for first 24–48h in severe ulcers. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What is the Ciprofloxacin (Ophthalmic) dose for cats?
For cats, Ciprofloxacin (Ophthalmic) is typically dosed as follows — Bacterial conjunctivitis / Secondary bacterial infection: 0 mg/kg Ophthalmic QID. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
What are the side effects of Ciprofloxacin (Ophthalmic)?
Common: Transient ocular stinging, White corneal precipitate (crystalline deposits). Serious (call your vet immediately): Corneal toxicity (rare with prolonged use).
Does Ciprofloxacin (Ophthalmic) need a prescription?
Yes. Ciprofloxacin (Ophthalmic) is a prescription medication and should only be administered under veterinary supervision.

References

References

Textbooks & handbooks

  • Plumb, D.C. Plumb's Veterinary Drug Handbook. 10th ed., Wiley-Blackwell, 2023.
  • Vail, D.M., Thamm, D.H., & Liptak, J.M. (eds.). Withrow & MacEwen's Small Animal Clinical Oncology. 6th ed., Saunders/Elsevier, 2020.
  • Riviere, J.E., & Papich, M.G. (eds.). Veterinary Pharmacology and Therapeutics. 10th ed., Wiley-Blackwell, 2018.
  • National Research Council. Nutrient Requirements of Dogs and Cats. National Academies Press, Washington DC, 2006.
  • The Merck Veterinary Manual. Merck & Co., Online edition. https://www.merckvetmanual.com/

Clinical guidelines & consensus

  • Fletcher, D.J., Boller, M., Brainard, B.M., et al. "RECOVER Evidence and Knowledge Gap Analysis on Veterinary CPR." Journal of Veterinary Emergency and Critical Care, 2012;22(S1):S102–S131.
  • American Animal Hospital Association. 2018 AAHA Diabetes Management Guidelines for Dogs and Cats. AAHA Press.

Journals & peer-reviewed studies

  • Hogan, D.F., Fox, P.R., Jacob, K., et al. "Secondary prevention of cardiogenic arterial thromboembolism in the cat: The FAT CAT study." Journal of Veterinary Cardiology, 2015;17(Suppl 1):S306–S317.
  • Boswood, A., Häggström, J., Gordon, S.G., et al. "Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study — A Randomized Clinical Trial." Journal of Veterinary Internal Medicine, 2016;30(6):1765–1779.
  • ASPCA Animal Poison Control Center. Toxicology and Poison Management Guidelines. American Society for the Prevention of Cruelty to Animals. https://www.aspca.org/pet-care/animal-poison-control

Regulatory & approvals

  • Central Drugs Standard Control Organisation (CDSCO), Government of India. Veterinary Drug Approval Registry, 1969–2026. Directorate General of Health Services. https://cdsco.gov.in/

Databases

  • Washington State University, College of Veterinary Medicine. Veterinary Clinical Pharmacology Laboratory (VCPL) — MDR1 Multidrug Sensitivity Database. https://vcpl.vetmed.wsu.edu/
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet. Find a vet near you →

Related medicines

Other medicines in the same class (Fluoroquinolone antibiotic).

Enrofloxacin
Rx
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication
dogcat
Marbofloxacin
Rx
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription
dogcat
Ofloxacin (Ophthalmic)
Rx
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription. Bactericidal activity against a wide range of gram-positive and gram-negative ocular pathogens.
dogcat